Chronic Disease Management

The chronic disease management market encompasses consumers with chronic, complex conditions such as chronic kidney disease, diabetes, and heart disease. The challenges faced in this market are often compounded by the need for social services and supports. For provider organizations and health systems managing consumers with chronic conditions, a significant challenge that remains is addressing the rising cost of care for this population. As a result, payers are focusing on reducing the spend by increasing integrated models of care coordination across medical, behavioural, pharmacy, and social support systems. These new market forces are creating strategic opportunities for provider organizations that are serving this population.

Latest Resources

• Alesis LLC Announces Joint Venture With First Sleep Center For Alesis OSA1 Treatment Of The Root Cause Of Most Sleep Apnea
• Alzheimer’s Association Launches (Re)think Your Brain To Drive Early Action On Brain Health
• Mercy Receives PCORI Funding To Expand Hypertension Care Program
• 17% Of Japanese Adults With Chronic Pain Screen Positive For ADHD
• CMS Launches $50 GLP-1 Medication Demonstration Program For Medicare Beneficiaries
• SanLuca & Sutter Health Partner On Behavioral Health Support For Hypertension Program
• Genetic Variants May Reduce GLP-1 Medication Effectiveness In 10% Of People With Type 2 Diabetes
• Chamber Cardio Raises $60 Million To Expand Value-Based Cardiovascular Care Platform
• Rightway Launches Weight Management Program To Support Employer GLP-1 Strategies
• Follow-Up Rates Similar For Virtual & In-Person Initial Neurology Visits, With Comparable 90-Day Utilization Across Conditions
• Amazon Launches GLP-1 Weight Management Program Integrating Primary Care, Pharmacy & Virtual Treatment Through One Medical
• Medicare Part D Subsidy Expansion Reduces Medication Non-Adherence By 5.5 Percentage Points
• Zócalo Health Raises $15 Million To Scale Community-Based Care For High-Need Populations
• 74% Of U.S. Adults Believe Chronic Disease Is Preventable, But Only 25% Feel Confident In Avoiding It
• Regen Therapy Partners With Stealth Health To Bring Specialized Telemedicine Services & Longevity Programs To 3,000 Clinics

See All

17% Of Japanese Adults With Chronic Pain Screen Positive For ADHD

Among Japanese adults with chronic pain, 17.1% screened positive for attention-deficit/hyperactivity disorder (ADHD), according to a recent study. The estimated ADHD prevalence among the general population of Japanese adults is 1.65%, compared to 17.1% among those with persistent chronic pain. The highest rate of ADHD-positive screenings, 27.4%, was among those who reported average pain levels of 9 or 10 on a 10-point pain severity scale. The data came from 958 adults who were first-time visitors… Read

• Breakthrough T1D Awards $1.5 Million Grant To Blue Circle Health To Expand Access To Care For Underserved Adults With Type 1 Diabetes
• Multiple Sclerosis Prevalence Doubled In Two Decades In England
• Prior Authorization Linked To Delays & Higher Non-Fill Rates For Heart Failure Medications
• CVS Health Foundation Awards $2.6 Million To Expand Maternal Diabetes Program In New York City
• Nimbus Healthcare & Snap Kitchen Launch Program Combining GLP-1 Therapy With Medically Tailored Meals

To sign-up for monthly Chronic Disease Management alerts, you must be signed in to your account.